0000899243-22-008015.txt : 20220228 0000899243-22-008015.hdr.sgml : 20220228 20220228134212 ACCESSION NUMBER: 0000899243-22-008015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211214 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARDINER SANDRA A. CENTRAL INDEX KEY: 0001218574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 22687019 MAIL ADDRESS: STREET 1: CUTERA, INC. STREET 2: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER NAME: FORMER CONFORMED NAME: GARDINER SANDRA DATE OF NAME CHANGE: 20030212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-14 0 0001625101 Pulse Biosciences, Inc. PLSE 0001218574 GARDINER SANDRA A. C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 CFO & EVP Admin. and Finance Stock Option (right to buy) 13.94 2021-12-14 4 A 0 25961 0.00 A 2021-12-14 2029-11-18 Common Stock 25961 51922 D On November 18, 2019, the reporting person was granted an option to purchase 103,842 shares of the issuer's common stock. The option vests based upon the achievement of performance objectives, with vesting targets no less than 25% vesting per year upon achievement of said objectives established by the Compensation Committee of the issuer, subject to the reporting person's continued service through each vesting date. The performance objectives for 2021 were met, resulting in the vesting of the option as to 25,961 shares. Represents the options which vested on the 2020 vesting date and the options which vested on the 2021 vesting date. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2022-02-28